References
- Deeg JH. Delayed complications after bone marrow transplantation. In: Forman SJ, Blume KG, Thomas ED, eds. Bone marrow transplantation. Boston: Blackwell, 1994:538-544.
- Fialkow PJ, Thomas ED, Bryant JI, Neiman PE. Leukaemic transformation of engrafted human marrow cells in vivo. Lancet 1971;1:251-255.
- Hertenstein B, Hambach L, Bacigalupo A, et al. Development of leukemia in donor cells after allogeneic stem cell transplantation: a survey of the European Group for Blood and Marrow Transplantation (EBMT). Haematologica 2005;90:969-975.
- Perla G, Bodenizza C, Falcone A, et al. Misleading cytogenetic evidence of relapse in donor cells after allogeneic bone marrow transplantation corrected by fluorescent in situ hybridization. Haematologica 1995;80:292-293.
- Naoe T, Kiyoi H, Yamanaka K, Naito K, Yamada K. A case of cALL relapse after allogeneic BMT: recurrence of recipient cell origin, initially determined as being that of donor cell origin by sex chromosome analysis. Br J Haematol 1989;73:420-422. https://doi.org/10.1111/j.1365-2141.1989.tb07766.x
- Spinelli O, Giussani U, Borleri G, et al. Need for an accurate molecular diagnosis to assess the donor origin of leukemia relapse after allogeneic stem cell transplantation. Haematologica 2000;85:1153-1157.
- Murata M, Ishikawa Y, Ohashi H, et al. Donor cell leukemia after allogeneic peripheral blood stem cell transplantation: a case report and literature review. Int J Hematol 2008;88:111-115. https://doi.org/10.1007/s12185-008-0094-3
- Ruiz-Arguelles A. Donor cell leukemia. Hematology 2012;17(Suppl 1):69-71.
Cited by
- A Case of Donor Cell Leukemia after Allogenic Peripheral Blood Stem Cell Transplantation for Acute Promyelocytic Leukemia with PML-RARA vol.10, pp.1, 2014, https://doi.org/10.3343/lmo.2020.10.1.88